Ann Arbor / Seattle / Houston / SAN ANTONIO / Boston / Greenville / Tuscon / Detroit / Washington / Lansing / / /
Facility
Statistical Center / Farber Cancer Institute / Arizona Cancer Center / National Cancer Institute / Ford Hospital / Health System Cancer Institute / The University of Texas Health Science Center / Baylor College of Medicine / University of Michigan Comprehensive Cancer Center / Anderson Cancer Center / /
IndustryTerm
Cancer Therapy / care for patients with breast cancer / Cancer Care / therapy for metastatic breast cancer / /
MedicalCondition
clinical cancer / metastatic breast cancer / either measurable disease / evaluable disease / breast cancer / cancers / tumor cell / bone metastases / tumor cells / /
MedicalTreatment
chemotherapy / chemotherapies / /
Organization
National Cancer Institute / Cancer Therapy & Research Center / 10SWOG Statistical Center / Seattle Cancer Care Alliance / 6Greenville Health System Cancer Institute / Baylor College of Medicine / 2MD Anderson Cancer Center / Arizona Cancer Center / SWOG Data Safety Monitoring Board / American Association for Cancer Research / University of Michigan Comprehensive Cancer Center / University of Texas Health Science Center at San Antonio / the University of Michigan / 7Henry Ford Hospital / 4Sanford Cancer Center / 3Dana-Farber Cancer Institute / /
Person
Jeffrey B. Smerage / Jeffrey Smerage / Jeremy Moore / Nicole Fawcett / / /
Position
physician / WB / clinical associate professor / /
Product
SC / /
ProvinceOrState
Texas / Washington / Michigan / South Carolina / Arizona / Massachusetts / /
Embargoed for Release: 7:30 a.m. CT, Dec. 13, 2013 To interview Jeffrey Smerage, contact Nicole Fawcett at [removed] or[removed]For a photo of Smerage, click here. For other inquiries, contact Jeremy Mo